Sun Pharma Fact Sheet, Sun Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma Fact Sheet    (SUNP)


Get Details: These 3 Stocks are the Dark Horses of the Stock Market


Here is the latest financial fact sheet of Sun Pharma. For more details, see the Sun Pharma quarterly results and Sun Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUN PHARMA Price History

Price Rs 594.5
Mkt Cap Rs m 1,430,694
Vol '000 168.4
P/E X 138.0
P/CF X 22.9
EPS (TTM) Rs 4.3
% ch % -0.3
No. of shares m 2,406.75
% ch week % -2.5
% ch 1-mth % 7.7
% ch 12-mth % 32.2
52 week H/L Rs 628.0/315.2
(As on Jan 20, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUN PHARMA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
SUN PHARMA EQUITY SHARE DATA
High Rs1,201842701679484 
Low Rs706572433375315 
Sales per share (Unadj.) Rs118.4131.6110.4121.1136.9 
Earnings per share (Unadj.) Rs23.532.710.713.417.5 
Diluted earnings per shareRs23.532.610.713.317.4 
Cash flow per share (Unadj.) Rs27.837.917.020.726.0 
Dividends per share (Unadj.) Rs1.003.502.002.754.00 
Adj. dividends per shareRs1.003.491.992.743.99 
Dividend yield (eoy) %0.10.50.40.51.0 
Book value per share (Unadj.) Rs137.1152.7159.7172.6188.7 
Adj. book value per shareRs137.0152.2159.2172.1188.1 
Shares outstanding (eoy) m2,406.602,399.262,399.262,399.262,399.26 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x8.15.45.14.42.9 
Avg P/E ratio x40.621.753.039.422.9 
P/CF ratio (eoy) x34.318.633.425.515.4 
Price / Book Value ratio x7.04.63.53.12.1 
Dividend payout %4.310.718.720.622.9 
Avg Mkt Cap Rs m2,294,8131,696,8771,360,0211,264,650958,864 
No. of employees `00014.717.517.817.517.8 
Total wages/salary Rs m47,72349,02353,67159,67163,624 
Avg. sales/employee Rs Th19,317.218,028.314,890.916,608.118,490.6 
Avg. wages/employee Rs Th3,236.12,798.83,017.13,409.63,582.6 
Avg. net profit/employee Rs Th3,836.94,473.81,443.61,833.82,357.6 
SUN PHARMA INCOME DATA
Net Sales Rs m284,870315,784264,895290,659328,375 
Other income Rs m6,5836,2328,38810,2556,360 
Total revenues Rs m291,453322,016273,282300,914334,735 
Gross profit Rs m81,583100,89356,08163,07669,898 
Depreciation Rs m10,37512,64814,99817,53320,528 
Interest Rs m5,2323,9985,1765,5533,027 
Profit before tax Rs m72,55890,47944,29550,24652,702 
Minority Interest Rs m00000 
Prior Period Items Rs m150000 
Extraordinary Inc (Exp) Rs m-6,8520-9,505-12,144-2,606 
Tax Rs m9,13812,1169,1106,0098,228 
Profit after tax Rs m56,58378,36325,67932,09341,868 
Gross profit margin %28.631.921.221.721.3 
Effective tax rate %12.613.420.612.015.6 
Net profit margin %19.924.89.711.012.8 
SUN PHARMA BALANCE SHEET DATA
Current assets Rs m299,413329,537316,359310,692316,542 
Current liabilities Rs m131,440178,870198,643173,396157,064 
Net working cap to sales %59.047.744.447.248.6 
Current ratio x2.31.81.61.82.0 
Inventory Days Days8279959988 
Debtors Days Days8783108112105 
Net fixed assets Rs m180,477204,766213,178232,477243,102 
Share capital Rs m2,4072,3992,3992,3992,399 
"Free" reserves Rs m327,418363,997380,742411,691450,245 
Net worth Rs m329,825366,397383,141414,091452,645 
Long term debt Rs m31,10314,36117,72115,22620,289 
Total assets Rs m555,303614,102645,164646,938682,525 
Interest coverage x14.923.69.610.018.4 
Debt to equity ratio x0.10000 
Sales to assets ratio x0.50.50.40.40.5 
Return on assets %11.113.44.85.86.6 
Return on equity %17.221.46.77.89.2 
Return on capital %19.724.810.010.211.2 
Exports to sales %13.90000 
Imports to sales %3.10000 
Exports (fob) Rs m39,5720000 
Imports (cif) Rs m8,8820000 
Fx inflow Rs m42,17144,11851,40366,02574,219 
Fx outflow Rs m21,58324,48432,23338,61027,964 
Net fx Rs m20,58819,63419,17027,41546,255 
SUN PHARMA CASH FLOW
From Operations Rs m 66,859 70,822 39,072 21,965 65,548 
From Investments Rs m -43,716 -42,216 -33,708 -6,813 -25,888 
From Financial Activity Rs m -18,885 -22,854 -15,393 -27,305 -57,151 
Net Cashflow Rs m 8,482 6,107 -7,359 -8,442 -13,857 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 63.7%
Foreign collaborators 0.0%
Indian inst/Mut Fund 5.1%
FIIs 23.0%
ADR/GDR 0.0%
Free float 8.3%
Shareholders 133,026
Pledged promoter(s) holding 0.5%
 

Company Information

REGD OFF Sun Pharma Advanced Research Centre, Tandalja, Vadodara - 390 020
E-MAIL sunil.ajmera@sunpharma.com WEB www.sunpharma.com
TELEPHONE (022) 6696 9696 FAX (022) 2821 2010
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Deloitte Haskins & Sells
CHM: Israel Makov COMP SEC: Sunil R. Ajmera YEAR OF INC: 1993 BSE CODE: 524715 FV (Rs): 1 DIV YIELD (%): 0.7

Read: SUN PHARMA 2019-20 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   INDRAPRASTHA MEDICAL  FULFORD INDIA  AUROBINDO PHARMA  NEULAND LABS  FRESENIUS KABI ONCO.  

Compare SUN PHARMA With:   INDRAPRASTHA MEDICAL  FULFORD INDIA  AUROBINDO PHARMA  NEULAND LABS  FRESENIUS KABI ONCO.  

Compare SUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex Ends at Record High; Tata Motors and Adani Ports Among Top Nifty Gainers(Closing)

Indian share markets extended gains to the second day today and ended at record-high levels with Nifty ending above 14,600-mark.

Views on news

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations (Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top (Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit (Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021 (Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA - WOCKHARDT COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS